Gvin1 inhibitors belong to a specific class of chemical compounds designed to modulate the activity of the Gvin1 protein. Gvin1, however, is a relatively lesser-known protein, and detailed information about its functions and physiological roles is limited. The precise functions of Gvin1 are still under investigation, and researchers are working to elucidate its roles within cellular and biochemical contexts. Gvin1 inhibitors are developed with the primary goal of selectively interacting with the Gvin1 protein, potentially influencing its activity and, consequently, impacting downstream cellular processes, although the specific pathways and functions influenced by Gvin1 are still largely uncharted.
Typically, Gvin1 inhibitors consist of small molecules or chemical compounds specifically designed to bind to Gvin1, targeting either its active site or allosteric sites. This interaction can lead to the modulation of Gvin1's behavior, potentially affecting its involvement in various cellular processes. Researchers are primarily focused on unraveling the biological functions and mechanisms of Gvin1 and how inhibiting its activity with these compounds may provide insights into cell biology and biochemical pathways. The development of Gvin1 inhibitors represents an ongoing area of research within the field of molecular pharmacology and biochemistry, contributing to our broader understanding of cellular processes and the functions of less-studied proteins like Gvin1.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING | 
|---|---|---|---|---|---|---|
| Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
| Actinomycin D intercalates into DNA, preventing RNA synthesis by inhibiting RNA polymerase, thereby reducing gene expression. | ||||||
| α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
| α-Amanitin strongly inhibits RNA polymerase II, which is pivotal in mRNA synthesis, potentially decreasing gene expression. | ||||||
| Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
| Rifampicin inhibits bacterial RNA polymerase, but in eukaryotic cells, it could affect mitochondrial RNA polymerase. | ||||||
| Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
| Triptolide has been shown to inhibit the transcription of several genes by affecting RNA polymerase II activity. | ||||||
| DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
| DRB inhibits RNA polymerase II transcription elongation, which can reduce overall gene expression. | ||||||
| Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
| Camptothecin inhibits topoisomerase I, which can lead to interference with transcription and reduction in gene expression. | ||||||
| Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $105.00 $408.00 $1224.00 | 35 | |
| Leptomycin B inhibits the export of mRNA from the nucleus to the cytoplasm, thereby indirectly reducing gene expression. | ||||||
| Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $182.00 $661.00 | 10 | |
| Chetomin disrupts the structure of eukaryotic transcription factor, inhibiting hypoxia-inducible factor-dependent transcription. | ||||||
| Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
| Flavopiridol inhibits cyclin-dependent kinases, which are necessary for RNA polymerase II phosphorylation and gene expression. | ||||||
| ICRF-193 | 21416-68-2 | sc-200889 sc-200889A | 1 mg 5 mg | $330.00 $898.00 | 7 | |
| ICRF-193 is a topoisomerase II inhibitor, which can lead to reduced transcription levels. | ||||||